ID   GLNA_RAT                Reviewed;         373 AA.
AC   P09606; Q6P7Q9;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   02-OCT-2024, entry version 185.
DE   RecName: Full=Glutamine synthetase {ECO:0000303|PubMed:2901064};
DE            Short=GS {ECO:0000303|PubMed:2901064};
DE            EC=6.3.1.2 {ECO:0000269|PubMed:28323};
DE   AltName: Full=Glutamate--ammonia ligase {ECO:0000305};
DE   AltName: Full=Palmitoyltransferase GLUL {ECO:0000305};
DE            EC=2.3.1.225 {ECO:0000250|UniProtKB:P15104};
GN   Name=Glul {ECO:0000312|RGD:2710}; Synonyms=Glns;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Wistar; TISSUE=Liver;
RX   PubMed=2901064; DOI=10.1093/nar/16.15.7726;
RA   van de Zande L., Labruyere W., Smaling M., Moorman A., Wilson R.H.,
RA   Charles R., Lamers W.H.;
RT   "Nucleotide sequence of rat glutamine synthetase mRNA.";
RL   Nucleic Acids Res. 16:7726-7726(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RX   PubMed=1970548; DOI=10.1016/0378-1119(90)90306-c;
RA   van de Zande L., Labruyere W.T., Arnberg A.C., Wilson R.H.,
RA   van de Bogaert A.J.W., Das A.T., van Oorschot D.A.J., Frijters C.,
RA   Charles R., Moorman A.F.M., Lamers W.H.;
RT   "Isolation and characterization of the rat glutamine synthetase-encoding
RT   gene.";
RL   Gene 87:225-232(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=1674354; DOI=10.1016/0169-328x(91)90003-g;
RA   Mill J.F., Mearow K.M., Purohit H.J., Haleem-Smith H., King R., Freese E.;
RT   "Cloning and functional characterization of the rat glutamine synthetase
RT   gene.";
RL   Brain Res. Mol. Brain Res. 9:197-207(1991).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=Brown Norway; TISSUE=Heart, and Pituitary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 15-41; 92-103; 190-213; 299-319 AND 341-357, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Spinal cord;
RA   Lubec G., Afjehi-Sadat L.;
RL   Submitted (NOV-2006) to UniProtKB.
RN   [6]
RP   ACTIVITY REGULATION.
RX   PubMed=4403443; DOI=10.1016/s0021-9258(20)81106-5;
RA   Tate S.S., Leu F.Y., Meister A.;
RT   "Rat liver glutamine synthetase. Preparation, properties, and mechanism of
RT   inhibition by carbamyl phosphate.";
RL   J. Biol. Chem. 247:5312-5321(1972).
RN   [7]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=28323; DOI=10.1016/s0021-9258(17)34587-8;
RA   Deuel T.F., Louie M., Lerner A.;
RT   "Glutamine synthetase from rat liver. Purification, properties, and
RT   preparation of specific antisera.";
RL   J. Biol. Chem. 253:6111-6118(1978).
RN   [8]
RP   TISSUE SPECIFICITY.
RX   PubMed=6138251; DOI=10.1002/j.1460-2075.1983.tb01464.x;
RA   Gebhardt R., Mecke D.;
RT   "Heterogeneous distribution of glutamine synthetase among rat liver
RT   parenchymal cells in situ and in primary culture.";
RL   EMBO J. 2:567-570(1983).
RN   [9]
RP   TISSUE SPECIFICITY.
RX   PubMed=7638749; DOI=10.1016/s0039-6060(05)80341-1;
RA   Abcouwer S.F., Lukascewicz G.C., Ryan U.S., Souba W.W.;
RT   "Molecular regulation of lung endothelial glutamine synthetase
RT   expression.";
RL   Surgery 118:325-334(1995).
RN   [10]
RP   INDUCTION.
RX   PubMed=18555765; DOI=10.1016/j.bone.2008.04.016;
RA   Olkku A., Mahonen A.;
RT   "Wnt and steroid pathways control glutamate signalling by regulating
RT   glutamine synthetase activity in osteoblastic cells.";
RL   Bone 43:483-493(2008).
CC   -!- FUNCTION: Glutamine synthetase that catalyzes the ATP-dependent
CC       conversion of glutamate and ammonia to glutamine (PubMed:28323). Its
CC       role depends on tissue localization: in the brain, it regulates the
CC       levels of toxic ammonia and converts neurotoxic glutamate to harmless
CC       glutamine, whereas in the liver, it is one of the enzymes responsible
CC       for the removal of ammonia (By similarity). Essential for proliferation
CC       of fetal skin fibroblasts. Independently of its glutamine synthetase
CC       activity, required for endothelial cell migration during vascular
CC       development: acts by regulating membrane localization and activation of
CC       the GTPase RHOJ, possibly by promoting RHOJ palmitoylation. May act as
CC       a palmitoyltransferase for RHOJ: able to autopalmitoylate and then
CC       transfer the palmitoyl group to RHOJ (By similarity). Plays a role in
CC       ribosomal 40S subunit biogenesis (By similarity). Through the
CC       interaction with BEST2, inhibits BEST2 channel activity by affecting
CC       the gating at the aperture in the absence of intracellular L-glutamate,
CC       but sensitizes BEST2 to intracellular L-glutamate, which promotes the
CC       opening of BEST2 and thus relieves its inhibitory effect on BEST2 (By
CC       similarity). {ECO:0000250|UniProtKB:P15104,
CC       ECO:0000250|UniProtKB:P15105, ECO:0000269|PubMed:28323}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-glutamate + NH4(+) = ADP + H(+) + L-glutamine +
CC         phosphate; Xref=Rhea:RHEA:16169, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:28938, ChEBI:CHEBI:29985, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:58359, ChEBI:CHEBI:456216; EC=6.3.1.2;
CC         Evidence={ECO:0000269|PubMed:28323};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=hexadecanoyl-CoA + L-cysteinyl-[protein] = CoA + S-
CC         hexadecanoyl-L-cysteinyl-[protein]; Xref=Rhea:RHEA:36683, Rhea:RHEA-
CC         COMP:10131, Rhea:RHEA-COMP:11032, ChEBI:CHEBI:29950,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57379, ChEBI:CHEBI:74151;
CC         EC=2.3.1.225; Evidence={ECO:0000250|UniProtKB:P15104};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:28323};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000269|PubMed:28323};
CC   -!- ACTIVITY REGULATION: Glutamine synthetase activity is inhibited by
CC       methionine sulfoximine (MSO). {ECO:0000269|PubMed:4403443}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=5 mM for L-glutamate (with 2 mM of Mn(2+))
CC         {ECO:0000269|PubMed:28323};
CC         KM=0.3 mM for L-glutamate (with 8 mM of Mn(2+))
CC         {ECO:0000269|PubMed:28323};
CC         KM=1.6 mM for L-glutamate (with 50 mM of Mg(2+))
CC         {ECO:0000269|PubMed:28323};
CC         KM=5.0 mM for L-glutamate (with 10 mM of Mg(2+))
CC         {ECO:0000269|PubMed:28323};
CC         KM=0.3 mM for NH(3) {ECO:0000269|PubMed:28323};
CC   -!- SUBUNIT: Decamer; composed of two pentamers (By similarity). Interacts
CC       with PALMD (By similarity). Interacts with RHOJ (By similarity).
CC       Interacts with BEST2; this interaction tethers a fraction of GLUL to
CC       the membrane, causing a decrease of cytosolic glutamine synthase (GS)
CC       activity and inhibits the chloride channel activity of BEST2 by
CC       affecting the gating at the aperture in the absence of intracellular
CC       glutamate (By similarity). {ECO:0000250|UniProtKB:P15104,
CC       ECO:0000250|UniProtKB:P15105}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000305|PubMed:28323}.
CC       Microsome {ECO:0000305|PubMed:28323}. Mitochondrion
CC       {ECO:0000305|PubMed:28323}. Cell membrane
CC       {ECO:0000250|UniProtKB:P15104}; Lipid-anchor
CC       {ECO:0000250|UniProtKB:P15104}. Note=Mainly localizes in the cytosol,
CC       with a fraction associated with the cell membrane.
CC       {ECO:0000250|UniProtKB:P15104}.
CC   -!- TISSUE SPECIFICITY: In the adult liver, expression is restricted to a
CC       small population of hepatocytes which form only a small rim of one to
CC       three hepatocytes around the central veins (PubMed:6138251). Expressed
CC       in lung microvascular endothelial cells (PubMed:7638749).
CC       {ECO:0000269|PubMed:6138251, ECO:0000269|PubMed:7638749}.
CC   -!- INDUCTION: By glucocorticoids (PubMed:18555765). Stimulated by the N-
CC       methyl-D-aspartate (NMDA) type glutamate receptor antagonist MK801
CC       (PubMed:18555765). Vitamin D and the Wnt signaling pathway inhibit its
CC       expression and activity (PubMed:18555765). Down-regulated during
CC       osteoblast mineralization (PubMed:18555765).
CC       {ECO:0000269|PubMed:18555765}.
CC   -!- PTM: Palmitoylated; undergoes autopalmitoylation.
CC       {ECO:0000250|UniProtKB:P15104}.
CC   -!- PTM: Acetylated by EP300/p300; acetylation is stimulated by increased
CC       glutamine levels and promotes ubiquitin-mediated proteasomal
CC       degradation. {ECO:0000250|UniProtKB:P15104}.
CC   -!- PTM: Ubiquitinated by ZNRF1 (By similarity). Ubiquitinated by the DCX
CC       (DDB1-CUL4-X-box) E3 ubiquitin-protein ligase complex called
CC       CRL4(CRBN), leading to proteasomal degradation (By similarity).
CC       {ECO:0000250|UniProtKB:P15104, ECO:0000250|UniProtKB:P15105}.
CC   -!- SIMILARITY: Belongs to the glutamine synthetase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X07921; CAA30754.1; -; mRNA.
DR   EMBL; M29599; AAA65096.1; -; Genomic_DNA.
DR   EMBL; M29595; AAA65096.1; JOINED; Genomic_DNA.
DR   EMBL; M29596; AAA65096.1; JOINED; Genomic_DNA.
DR   EMBL; M29597; AAA65096.1; JOINED; Genomic_DNA.
DR   EMBL; M29598; AAA65096.1; JOINED; Genomic_DNA.
DR   EMBL; M29579; AAA65095.1; -; mRNA.
DR   EMBL; M91652; AAC42038.1; -; mRNA.
DR   EMBL; BC061559; AAH61559.1; -; mRNA.
DR   EMBL; BC072694; AAH72694.1; -; mRNA.
DR   PIR; S01242; AJRTQ.
DR   RefSeq; NP_058769.4; NM_017073.3.
DR   AlphaFoldDB; P09606; -.
DR   SMR; P09606; -.
DR   BioGRID; 247058; 4.
DR   IntAct; P09606; 3.
DR   MINT; P09606; -.
DR   STRING; 10116.ENSRNOP00000065890; -.
DR   CarbonylDB; P09606; -.
DR   GlyGen; P09606; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P09606; -.
DR   PhosphoSitePlus; P09606; -.
DR   SwissPalm; P09606; -.
DR   PaxDb; 10116-ENSRNOP00000065890; -.
DR   Ensembl; ENSRNOT00055031714; ENSRNOP00055025642; ENSRNOG00055018616.
DR   Ensembl; ENSRNOT00060024776; ENSRNOP00060019737; ENSRNOG00060014474.
DR   Ensembl; ENSRNOT00065043299; ENSRNOP00065035495; ENSRNOG00065025118.
DR   GeneID; 24957; -.
DR   KEGG; rno:24957; -.
DR   AGR; RGD:2710; -.
DR   CTD; 2752; -.
DR   RGD; 2710; Glul.
DR   VEuPathDB; HostDB:ENSRNOG00000049560; -.
DR   eggNOG; KOG0683; Eukaryota.
DR   HOGENOM; CLU_036762_1_1_1; -.
DR   InParanoid; P09606; -.
DR   PhylomeDB; P09606; -.
DR   BRENDA; 6.3.1.2; 5301.
DR   Reactome; R-RNO-210455; Astrocytic Glutamate-Glutamine Uptake And Metabolism.
DR   Reactome; R-RNO-8964539; Glutamate and glutamine metabolism.
DR   PRO; PR:P09606; -.
DR   Proteomes; UP000002494; Chromosome 13.
DR   Bgee; ENSRNOG00000049560; Expressed in frontal cortex and 19 other cell types or tissues.
DR   GO; GO:0043679; C:axon terminus; IDA:RGD.
DR   GO; GO:0044297; C:cell body; ISO:RGD.
DR   GO; GO:0042995; C:cell projection; IDA:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; IEA:UniProtKB-KW.
DR   GO; GO:0097386; C:glial cell projection; ISO:RGD.
DR   GO; GO:0005739; C:mitochondrion; IEA:UniProtKB-SubCell.
DR   GO; GO:0043209; C:myelin sheath; IDA:UniProtKB.
DR   GO; GO:0043204; C:perikaryon; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0032991; C:protein-containing complex; IDA:RGD.
DR   GO; GO:0005524; F:ATP binding; IDA:RGD.
DR   GO; GO:0045503; F:dynein light chain binding; IPI:RGD.
DR   GO; GO:0016595; F:glutamate binding; IDA:RGD.
DR   GO; GO:0004356; F:glutamine synthetase activity; IDA:RGD.
DR   GO; GO:0042802; F:identical protein binding; IPI:RGD.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:RGD.
DR   GO; GO:0030145; F:manganese ion binding; IDA:RGD.
DR   GO; GO:0016151; F:nickel cation binding; IDA:RGD.
DR   GO; GO:0019706; F:protein-cysteine S-palmitoyltransferase activity; ISS:UniProtKB.
DR   GO; GO:0019676; P:ammonia assimilation cycle; IDA:RGD.
DR   GO; GO:0001525; P:angiogenesis; IEA:UniProtKB-KW.
DR   GO; GO:0008283; P:cell population proliferation; ISO:RGD.
DR   GO; GO:0009267; P:cellular response to starvation; ISO:RGD.
DR   GO; GO:0006536; P:glutamate metabolic process; IDA:RGD.
DR   GO; GO:0006542; P:glutamine biosynthetic process; IDA:RGD.
DR   GO; GO:0050679; P:positive regulation of epithelial cell proliferation; IMP:RGD.
DR   GO; GO:0032024; P:positive regulation of insulin secretion; IMP:RGD.
DR   GO; GO:0051968; P:positive regulation of synaptic transmission, glutamatergic; IMP:RGD.
DR   GO; GO:0018345; P:protein palmitoylation; ISS:UniProtKB.
DR   GO; GO:0010594; P:regulation of endothelial cell migration; ISS:UniProtKB.
DR   GO; GO:1904749; P:regulation of protein localization to nucleolus; ISO:RGD.
DR   GO; GO:1903670; P:regulation of sprouting angiogenesis; ISS:UniProtKB.
DR   GO; GO:0009749; P:response to glucose; ISO:RGD.
DR   GO; GO:0042254; P:ribosome biogenesis; ISO:RGD.
DR   Gene3D; 3.10.20.70; Glutamine synthetase, N-terminal domain; 1.
DR   Gene3D; 3.30.590.10; Glutamine synthetase/guanido kinase, catalytic domain; 2.
DR   InterPro; IPR008147; Gln_synt_N.
DR   InterPro; IPR036651; Gln_synt_N_sf.
DR   InterPro; IPR014746; Gln_synth/guanido_kin_cat_dom.
DR   InterPro; IPR008146; Gln_synth_cat_dom.
DR   InterPro; IPR027303; Gln_synth_gly_rich_site.
DR   InterPro; IPR027302; Gln_synth_N_conserv_site.
DR   InterPro; IPR050292; Glutamine_Synthetase.
DR   PANTHER; PTHR20852; GLUTAMINE SYNTHETASE; 1.
DR   PANTHER; PTHR20852:SF45; GLUTAMINE SYNTHETASE; 1.
DR   Pfam; PF00120; Gln-synt_C; 1.
DR   Pfam; PF03951; Gln-synt_N; 1.
DR   SMART; SM01230; Gln-synt_C; 1.
DR   SUPFAM; SSF54368; Glutamine synthetase, N-terminal domain; 1.
DR   SUPFAM; SSF55931; Glutamine synthetase/guanido kinase; 1.
DR   PROSITE; PS00180; GLNA_1; 1.
DR   PROSITE; PS00181; GLNA_ATP; 1.
DR   PROSITE; PS51986; GS_BETA_GRASP; 1.
DR   PROSITE; PS51987; GS_CATALYTIC; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Angiogenesis; ATP-binding; Cell membrane; Cytoplasm;
KW   Direct protein sequencing; Endoplasmic reticulum; Ligase; Lipoprotein;
KW   Magnesium; Manganese; Membrane; Metal-binding; Microsome; Mitochondrion;
KW   Nucleotide-binding; Palmitate; Phosphoprotein; Reference proteome;
KW   Transferase; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P15105"
FT   CHAIN           2..373
FT                   /note="Glutamine synthetase"
FT                   /id="PRO_0000153143"
FT   DOMAIN          24..106
FT                   /note="GS beta-grasp"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01330"
FT   DOMAIN          113..373
FT                   /note="GS catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01331"
FT   REGION          2..25
FT                   /note="Required for glutamine-induced ubiquitination by
FT                   CRL4(CRBN) and proteasomal degradation"
FT                   /evidence="ECO:0000250|UniProtKB:P15104"
FT   BINDING         134
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P15104"
FT   BINDING         134
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P15104"
FT   BINDING         136
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P15104"
FT   BINDING         196
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P15104"
FT   BINDING         203..208
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P15104"
FT   BINDING         203
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P15104"
FT   BINDING         246..247
FT                   /ligand="L-glutamate"
FT                   /ligand_id="ChEBI:CHEBI:29985"
FT                   /evidence="ECO:0000250|UniProtKB:P9WN39"
FT   BINDING         253
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P15104"
FT   BINDING         255..257
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P15104"
FT   BINDING         319
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P15104"
FT   BINDING         319
FT                   /ligand="L-glutamate"
FT                   /ligand_id="ChEBI:CHEBI:29985"
FT                   /evidence="ECO:0000250|UniProtKB:P9WN39"
FT   BINDING         324
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P15104"
FT   BINDING         336..338
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000250|UniProtKB:P15104"
FT   BINDING         338
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P15104"
FT   BINDING         340
FT                   /ligand="L-glutamate"
FT                   /ligand_id="ChEBI:CHEBI:29985"
FT                   /evidence="ECO:0000250|UniProtKB:P9WN39"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000250|UniProtKB:P15105"
FT   MOD_RES         11
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P15104"
FT   MOD_RES         14
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P15104"
FT   MOD_RES         104
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P15105"
FT   MOD_RES         343
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P15104"
FT   CONFLICT        74
FT                   /note="N -> D (in Ref. 4; AAH61559)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        128
FT                   /note="H -> R (in Ref. 3; AAC42038)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   373 AA;  42268 MW;  A7C12D9C5959BCA1 CRC64;
     MATSASSHLN KGIKQMYMNL PQGEKIQLMY IWVDGTGEGL RCKTRTLDCD PKCVEELPEW
     NFDGSSTFQS EGSNSDMYLH PVAMFRDPFR RDPNKLVFCE VFKYNRKPAE TNLRHSCKRI
     MDMVSSQHPW FGMEQEYTLM GTDGHPFGWP SNGFPGPQGP YYCGVGADKA YGRDIVEAHY
     RACLYAGIKI TGTNAEVMPA QWEFQIGPCE GIRMGDHLWV ARFILHRVCE DFGVIATFDP
     KPIPGNWNGA GCHTNFSTKA MREENGLRCI EEAIDKLSKR HQYHIRAYDP KGGLDNARRL
     TGFHETSNIN DFSAGVANRS ASIRIPRIVG QEKKGYFEDR RPSANCDPYA VTEAIVRTCL
     LNETGDEPFQ YKN
//
